(Q36480958)

14 August 2017

title

Gram-positive cocci infections in intensive care: guide to antibacterial selection (English)

1 reference

14 August 2017

main subject

gram-positive bacteria

0 references

author name string

Francisco Alvarez-Lerma

series ordinal

1

1 reference

14 August 2017

Santiago Grau

series ordinal

2

1 reference

14 August 2017

Maria-Pilar Gracia-Arnillas

series ordinal

3

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

66

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

751-768

1 reference

Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

De-escalation therapy in ventilator-associated pneumonia

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

21 January 2018

12 December 2020

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666060-00003

Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

21 January 2018

1 reference

12 December 2020

Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals

1 reference

12 December 2020

Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

1 reference

12 December 2020

[Initial empirical antibiotic treatment of community-acquired pneumonia]

1 reference

12 December 2020

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

1 reference

12 December 2020

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

12 December 2020

Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time

1 reference

12 December 2020

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

1 reference

12 December 2020

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

1 reference

12 December 2020

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

12 December 2020

Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes

1 reference

12 December 2020

Management of antimicrobial use in the intensive care unit

1 reference

12 December 2020

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Coagulase-negative staphylococcal infections: an update regarding recognition and management

1 reference

12 December 2020

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci

1 reference

12 December 2020

Nosocomial Respiratory Tract Infections in Multiple Trauma Patients

1 reference

12 December 2020

A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.

1 reference

12 December 2020

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy

1 reference

12 December 2020

Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)

1 reference

12 December 2020

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

12 December 2020

Methicillin-resistant staphylococci and their treatment in the intensive care unit

1 reference

12 December 2020

Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity

1 reference

12 December 2020

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

1 reference

12 December 2020

High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.

1 reference

12 December 2020

The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia

1 reference

12 December 2020

Survey of enterococcal susceptibility patterns in Belgium.

1 reference

12 December 2020

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

1 reference

12 December 2020

Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae

1 reference

12 December 2020

1 reference

12 December 2020

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

12 December 2020

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

12 December 2020

Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections

1 reference

12 December 2020

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

12 December 2020

Identification of risk times for dissemination of methicillin-resistant Staphylococcus aureus in an intensive care unit

1 reference

12 December 2020

Multiple Pharmacokinetic Parameter Prediction for a Series of Cephalosporins

1 reference

12 December 2020

Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features

1 reference

12 December 2020

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

12 December 2020

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study

1 reference

12 December 2020

Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients

1 reference

12 December 2020

Investigation of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR).

1 reference

12 December 2020

Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions

1 reference

12 December 2020

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

12 December 2020

A pharmacoeconomic model to evaluate antibiotic costs.

1 reference

12 December 2020

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model

1 reference

12 December 2020

Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview

1 reference

12 December 2020

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections

1 reference

12 December 2020

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

12 December 2020

Dexamethasone in adults with bacterial meningitis

1 reference

12 December 2020

Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

1 reference

12 December 2020

Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.

1 reference

12 December 2020

High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae

1 reference

12 December 2020

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

1 reference

12 December 2020

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

1 reference

12 December 2020

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

12 December 2020

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

12 December 2020

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

12 December 2020

Monitoring plasma antibiotic concentrations in Spanish hospitals

1 reference

12 December 2020

Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain

1 reference

12 December 2020

Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model

1 reference

12 December 2020

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

1 reference

12 December 2020

Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens

1 reference

12 December 2020

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

1 reference

12 December 2020

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey

1 reference

12 December 2020

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

1 reference

12 December 2020

The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations

1 reference

12 December 2020

Staphylococcus aureus resistant to vancomycin--United States, 2002.

1 reference

12 December 2020

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin

1 reference

12 December 2020

The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration

1 reference

12 December 2020

Staphylococcus aureus nosocomial infections in critically ill patients admitted in intensive care units

1 reference

12 December 2020

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

1 reference

12 December 2020

Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.

1 reference

12 December 2020

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

1 reference

12 December 2020

The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus.

1 reference

12 December 2020

MRSA pneumonia: better outcome through continuous infusion of vancomycin?

1 reference

12 December 2020

Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model

1 reference

12 December 2020

Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

1 reference

12 December 2020

Linezolid resistance in a clinical isolate of Staphylococcus aureus

1 reference

12 December 2020

Antimicrobial susceptibility and pneumococcal serotypes

1 reference

12 December 2020

Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program

1 reference

12 December 2020

Vancomycin-resistant enterococcal infections

1 reference

12 December 2020

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

1 reference

12 December 2020

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

1 reference

12 December 2020

The pharmacokinetic and pharmacodynamic properties of vancomycin

1 reference

12 December 2020

Resistance among Streptococcus pneumoniae: Implications for drug selection

1 reference

12 December 2020

Telavancin: in vitro activity against staphylococci in a biofilm model

1 reference

12 December 2020

Early onset pneumonia: a multicenter study in intensive care units

1 reference

12 December 2020

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy

1 reference

12 December 2020

10.2165/00003495-200666060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1012467577

0 references

1 reference